Part-Time

Quality Assurance and Regulatory Associate

Quality Assurance, Regulatory Affairs

Posted on 9/26/2025

ZOLL Medical Corporation

ZOLL Medical Corporation

1,001-5,000 employees

Cardiac resuscitation devices with integrated software

No salary listed

Sydney NSW, Australia

In Person

Part-time capacity (2.5 days per week) in-office.

Category
QA & Testing (1)
Required Skills
Risk Management
Requirements
  • Minimum 3–5 years' experience in a WHS or QA function with Australian legislative experience.
  • Proven understanding of WHS laws in Australia and related frameworks (SafeWork Australia, Model Codes of Practice).
  • Familiarity with quality standards including ISO 9001, ISO 13485, and TGA medical device compliance.
  • Demonstrated experience writing and managing Australian WHS and QA documentation and systems.
  • Strong incident investigation, risk management, and audit preparation capabilities.
  • Ability to influence and educate senior leaders on their legal responsibilities and risk exposure under Australian law.
  • Certificate IV WHS or equivalent required; formal audit or quality systems training highly desirable.
  • Strong communication skills.
  • Attention to detail.
  • Flexible
Responsibilities
  • Ensure ZOLL Medical’s operations in Australia meet the requirements of the Work Health and Safety Act 2011 (Cth) and relevant state/territory-based WHS laws, including SafeWork NSW, WorkSafe VIC, WorkSafe QLD, and others as applicable.
  • Monitor changes in Australian legislation, codes of practice, and industry standards, and provide advice to local leadership regarding their implications.
  • Liaise with relevant government agencies regulators and external consultants within Australia to ensure alignment and compliance (e.g. Safe Work Australia, TGA, ISO certifying bodies).
  • Ensure the Company Director and senior managers are aware of their duties as Officers under Section 27 of the WHS Act, and provide appropriate support, resources, and documentation to meet their obligations.
  • Prepare the business for internal and external audits and represent the company in inspections and WHS compliance reviews conducted by Australian regulators.
  • Develop and implement a local WHS strategy that supports ZOLL Medical’s commitment to creating a safe and healthy workplace, aligned to Australian legal obligations and cultural expectations.
  • Design, implement, and manage a WHS Management System (WHSMS) that is robust, auditable, and appropriate to the business’s risk profile and operations.
  • Conduct and document risk assessments, safety audits, site inspections, and compliance monitoring across all Australian operations.
  • Lead the development and delivery of local safety training, onboarding modules, toolbox talks, emergency drills, and employee education programs to ensure awareness and engagement with WHS responsibilities.
  • Act as a key escalation point for safety concerns and incidents, ensuring that investigations are carried out and reported appropriately to regulators, with full documentation and response management in line with Australian standards.
  • Manage and maintain a Quality Management System (QMS) that supports compliance with ISO 9001, ISO 13485, and TGA expectations specific to the Australian medical device sector.
  • Write, update, and control all QA documentation to ensure that it is owned and governed locally, including SOPs, work instructions, corrective actions, preventive actions (CAPA), deviation reports, and quality records.
  • Conduct internal QA audits and oversee external audit preparedness, coordinating with relevant business units to drive a culture of accountability and quality.
  • Work closely with the ANZ Senior Management, Operations, and Service teams to ensure quality standards are embedded into all internal processes and external service delivery across Australia and New Zealand.
  • Maintain National Pricing Catalogue for Contracts.
  • Support the development and management of a comprehensive risk management framework for the Australian business, with WHS and QA risks formally registered and reviewed regularly.
  • Provide advice and support to the Company Director and Officers of the business to ensure they meet their legal duty of due diligence in relation to workplace safety, quality compliance, and audit readiness.
  • Document and report risks, actions, incidents, and regulatory obligations in a transparent, structured manner that can be reviewed at board and leadership level.
  • Ensure the business maintains robust, real-time documentation that can support legal defensibility in the event of incident investigations, legal action, or insurance claims.
  • Provide input into governance structures such as risk registers, policy reviews, and WHS/QA reporting packs for leadership meetings.
  • Write, maintain, and review all WHS and QA policies, manuals, and procedural documents used by Australian staff, ensuring alignment to local legislative and operational requirements.
  • Maintain the Australian Policy Register, managing version control, approval workflows, expiry schedules, and historical change logs.
  • Ensure all documentation — including price guides, service instructions, operational checklists, and reporting tools — are written for and governed by Australian standards only.
  • Prevent the direct application of international templates or APAC/US policies that have not been assessed and adapted for legal, operational, and cultural appropriateness within Australia.
  • Promote a safety-first mindset and foster a culture of shared responsibility, continuous improvement, and proactive risk management.
  • Lead WHS committee participation or engagement forums and maintain a visible presence as a trusted advisor and champion for safety and quality across the Australian business.
  • Identify gaps, trends, and opportunities for improvement using audits, employee feedback, and incident data, and implement meaningful, measurable improvements.
  • While this role is based in and reports through Australia, it also supports ZOLL Medical’s New Zealand operations in partnership with the NZ Manager.
  • Quality and safety frameworks implemented in New Zealand must meet the Health and Safety at Work Act 2015 (NZ) and align with NZS ISO 9001 and NZS ISO 13485 standards.
  • This role ensures consistency across both countries while maintaining compliance with the distinct legal and regulatory environments in each.
  • Documentation and audit processes will be tailored for New Zealand requirements and supported locally by this role, under Australian governance.
Desired Qualifications
  • Formal audit or quality systems training highly desirable.
ZOLL Medical Corporation

ZOLL Medical Corporation

View

ZOLL Medical Corporation designs and sells medical devices and software for emergency and critical care. Its products include defibrillators and AEDs, mobile ECG systems, disposable electrodes, temperature management devices, sleep apnea solutions, and software that integrates with hardware to manage patient data. It differentiates itself by offering an integrated hardware-software ecosystem focused on cardiac resuscitation and critical care with a global reach to hospitals and EMS. Its goal is to improve patient outcomes and clinical and operational efficiency through end-to-end, data-enabled emergency and critical care solutions.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$2.2B

Headquarters

Chelmsford, Massachusetts

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Eric Knudsen's CEO appointment drives growth from 30 years medtech expertise.
  • ZOLL Itamar achieves profitability surge under Knudsen's prior leadership.
  • EU MDR approval expands Zenix sales in Europe for hospitals and EMS.

What critics are saying

  • Medtronic LifePak captures 45% US EMS share, eroding X Series sales.
  • Stryker LUCAS 4 beats AutoPulse NXT by 18% ROSC in 2025 AHA trials.
  • ResMed NightOwl halves ZOLL Itamar's $200M sleep diagnostics revenue.

What makes ZOLL Medical Corporation unique

  • Zenix defibrillator offers Real CPR Help and touchscreen customization for EMS.
  • TherOx SSO2 Therapy gains Vizient contract for post-heart attack oxygen delivery.
  • AutoPulse NXT deployed nationwide by Air Methods for air medical transports.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Casual Work Environment

Company News

Business Wire
Feb 10th, 2026
ZOLL's Zenix monitor/defibrillator receives EU MDR approval for EMS and hospital use

ZOLL, an Asahi Kasei company manufacturing medical devices, has announced that its Zenix monitor/defibrillator received approval under the European Union Medical Device Regulation 2017/745. The device is designed for use in both emergency medical services and hospital settings. Zenix features a large touchscreen and on-the-fly customisation capabilities, allowing healthcare professionals to make real-time adjustments during critical situations. The device incorporates ZOLL's Real BVM Help and Real CPR Help technology, providing clinical feedback to improve ventilation quality and CPR delivery. According to Elijah White, president of ZOLL Acute Care Technology, virtually all device functions are accessible with three screen-touches or fewer. Zenix joins ZOLL's existing portfolio of professional monitors and defibrillators, including the X Series, R Series and M2 models.

The AI Journal Ltd
Feb 4th, 2026
ZOLL Medical Appoints Eric Knudsen as New CEO

ZOLL medical appoints Eric Knudsen as new CEO. CHELMSFORD, Mass. - (BUSINESS WIRE) - ZOLL(R), an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL's CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL's Board of Directors. "As a global leader in medical technology, ZOLL is continually looking for ways to expand our business and reach more patients in need," said Rennert. "Eric has played a unique role in developing our growth strategies and driving our expansion, and I am confident he will lead ZOLL to even greater growth and success." "I am honored to become ZOLL's next CEO," said Knudsen. "ZOLL has a long legacy of innovation and clinical excellence, and today our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. We will continue to lead with our commitment to patients and customers and our passion for improving outcomes and helping save lives." Knudsen has nearly 30 years of experience in the medtech industry, with deep expertise in business development and corporate strategy. He led ZOLL's Corporate Development team for six years and was responsible for investing in strategic relationships and acquiring more than a dozen new technologies. For the past four years, Knudsen was President of ZOLL Itamar, a division of ZOLL that is focused on the diagnosis of sleep disorders. Knudsen led the division through significant growth and a dramatic increase in profitability. Prior to joining ZOLL in 2013, Knudsen held leadership positions in international sales, marketing, and manufacturing partnerships at Covidien (now Medtronic), Aspect Medical Systems, and LeMaitre Vascular. He has an MBA from the Thunderbird School of Global Management and a bachelor's degree from Boston College. Rennert was named CEO of ZOLL in 2016, after serving as President of the company's largest business unit for eight years. Under Rennert's leadership as CEO, ZOLL expanded its reach as a global leader in external defibrillation, pioneered novel solutions for patients with serious cardiopulmonary and respiratory conditions, and significantly broadened its portfolio of products. About ZOLL ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com. About Asahi Kasei The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Healthcare, Homes, and Material. Its healthcare operations include devices and systems for critical care, products and services for the manufacture of biotherapeutics, and a growing portfolio of specialty pharmaceuticals. For more information, visit www.asahi-kasei.com. Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/. Matt Hogan ZOLL 978-805-6561 [email protected]

Air Methods
May 1st, 2025
Air Methods Enhances Patient Care and Safety with Nationwide Deployment of Zoll(R) AutoPulse(R) NXT

Air Methods collaborated closely with ZOLL to provide direct feedback during the development of the AutoPulse NXT, which was released in 2024.

ZOLL Data Systems
Aug 6th, 2024
Black Book Research Ranks ZOLL(R) AR Boost(R) as the #1 2024 Insurance Discovery Solution

The ZOLL AR Boost(R) Insurance Discovery tool secured the #1 spot in the 2024 Insurance Discovery Solutions category.

Law360
Apr 12th, 2024
Zoll Says 'Cookie-Cutter' Hack Claims Don't Show Harm

Zoll Medical Corp. is asking a Boston federal judge to toss a proposed class action brought by medical device customers whose personal information was released during a ransomware attack last year...

INACTIVE